Search clinical trials for: 19-195

Total 15265 results

EuBiologics Co.,Ltd

Completed

A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

COVID-19

Congo, The Democratic Republic of the
EuBiologics Co.,Ltd

Completed

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

COVID-19

Philippines
Makerere University

Active, not recruiting

Hydroxychloroquine for Treatment of Non-Severe COVID-19 (HONEST)

Covid19

Uganda
Duke University
North Carolina Department of Health and Human Services

Completed

MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study (C3PI)

COVID 19

United States
VA Eastern Colorado Health Care System

Completed

Identifying the Needs of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans and Their Families: TBI and Co-Occurring Behavioral Health Issues

Traumatic Brain Injury | Co-Occurring Behavioral Health Issues

United States
Shanghai Unicar-Therapy Bio-medicine Technology...

Recruiting

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

China
Fujian Medical University

Unknown

CART-19 Cells For MRD Positive CD19+ ALL (CCFMPCA)

Acute Lymphoblastic Leukemia

China
University of Sao Paulo
Hospital das Clínicas de Ribeirão Preto; Blood Center of Ribeirao Preto

Not yet recruiting

CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma (CARTHEDRALL)

Lymphoma, Non-Hodgkin | Leukemia, Acute Lymphoblastic

Brazil
University of Pennsylvania

Completed

Dose Optimization Trial of CD19 Redirected Autologous T Cells

Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL

United States
University of Pennsylvania

Completed

Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma (Pedi CART19)

B Cell Lymphoma | B Cell Leukemia

United States
EmitBio Inc.
NAMSA

Active, not recruiting

Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting (EB-PCC-01)

Post COVID-19 Condition (PCC)

United States
University of Pennsylvania

Completed

Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia

Patients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment Options

United States
University of Pennsylvania

Completed

CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy

Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Hematopoietic/Lymphoid Cancer | Adult Acute Lymphoblastic Leukemia in Remission | B-cell Chronic Lymphocytic... and other conditions

United States
University of Pennsylvania

Terminated

Allo CART-19 Protocol

Acute Lymphocytic Leukemia

United States
Beijing Sanwater Biological Technology Co., Ltd.

Unknown

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

China
Sona Nanotech Inc
Nova Scotia Health Authority

Completed

Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19

Sars-CoV-2 Infection

Canada
Nanogen Pharmaceutical Biotechnology Joint Stock...
Vietstar Biomedical Research; MedProve Inc

Completed

Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients

Breast Cancer Recurrent | Breast Cancer Female | Breast Cancer Metastatic

Vietnam
Nanogen Pharmaceutical Biotechnology Joint Stock...
Vietstar Biomedical Research; MedProve Inc

Completed

Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.

Breast Cancer Recurrent | Breast Cancer Female | Breast Cancer Metastatic

Vietnam
Black Sea Hematology Association
Amgen

Unknown

Carfilzomib in Combination for the Treatment of RR MM

Multiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple Myeloma

Turkey
PATH

Completed

Feasibility and Usability of COVID-19 Antigen RDTs in Uganda

COVID-19 Pandemic

Uganda
Federal University of Espirito Santo
Centro de Pesquisas René Rachou; Secretaria de Estado da Saúde do Espírito...

Not yet recruiting

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly (Plus_Booster)

COVID-19 | Vaccine Adverse Reaction | Vaccine-Preventable Diseases

Brazil
Geisinger Clinic

Completed

Comparison of 19g FNA and 19g FNB Needles for EUS-LB

Abnormal Liver Function

United States
Kaleido Biosciences

Completed

Clinical Food Study to Evaluate the Effect of KB195 on Gut Nitrogen Metabolism in Patients With Urea Cycle Disorders

Urea Cycle Disorders

Switzerland
Emory University

Withdrawn

Cetirizine and Famotidine for COVID-19

Covid19

United States
Assaf-Harofeh Medical Center

Completed

Evaluating the Immune Response for COVID-19 (COVIDIMMUNE)

COVID-19

Israel
Xavier University of Louisiana.

Completed

COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana

Covid19 | Vaccine Hesitancy | Vaccine Refusal

United States
University of Oxford

Active, not recruiting

Investigating a Vaccine Against COVID-19

Coronavirus

United Kingdom
Kocak Farma

Recruiting

Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo

COVID-19 Vaccine

Turkey
University of Pennsylvania

Withdrawn

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma
Unidad Temporal COVID-19 en Centro Citibanamex
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto...

Completed

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 (ANTIOX-COVID)

Pneumonia, Viral | Covid19 | Oxidative Stress | ARDS

Mexico
Centre Hospitalier Universitaire de Saint Etienne
Sanofi Pasteur, a Sanofi Company; Bioster, a.s.

Completed

Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19 (COVIMMUNAGE)

Covid19

France
Laboratorios Hipra, S.A.

Completed

Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19)

Covid19 | SARS CoV 2 Infection

Spain
Perseverance Research Center, LLC
Athena Medical Group

Unknown

Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 (COVID-19)

COVID-19

United States
Izmir Democracy University

Recruiting

Pain, Physical Activity, Posture and Quality of Life in Post-COVID-19 Individuals With Idiopathic Scoliosis

Idiopathic Scoliosis | COVID-19 Respiratory Infection

Turkey
Izmir Democracy University

Recruiting

Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19

Parkinson Disease | COVID-19 Respiratory Infection

Turkey
Chr Hansen
Atlantia Food Clinical Trials

Terminated

The Effect of a Probiotic Strain on Aspirin-induced GI Damage (PIP-L)

Reduction of Small Intestinal Ulceration Risk

United States
Rush University Medical Center
National Institute of Nursing Research (NINR)

Completed

Increasing COVID-19 Testing in Chicago's African American Testing Desserts

COVID-19 Pandemic

United States
Duke University

Completed

Test to Stay in School: COVID-19 Testing Following Exposure in School Communities

Covid19

United States
University of Pennsylvania

Terminated

Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)

LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)

United States
Centre Hospitalier Universitaire de Nice

Completed

Assesment of the Metabolomic Signature in COVID-19 Patients (SignCov)

COVID 19

France
Groupe Hospitalier de la Rochelle Ré Aunis
NumaHealth International

Completed

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection (STC-19)

Covid19 | SARS-CoV-2 Acute Respiratory Disease

France
Vrije Universiteit Brussel
Universitair Ziekenhuis Brussel

Completed

COVID-19 and the Brain

Covid19 | Brain | fMRI | Neurocognition

Belgium
Mansoura University

Completed

The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice

COVID | Critical Limb Ischemia

Egypt
St. Joseph's Healthcare Hamilton
Timothy O'Shea; Marek Smieja; Lawrence Mbuagbaw

Unknown

COVID Screening Strategies in Homeless Shelters

COVID-19

Canada
Fujian Medical University

Unknown

CART-19 Cells for R/R B-cell Lymphoma (CCFRRBL)

Relapsed or Refractory B-cell Lymphoma

China
Texas Woman's University
National Institutes of Health (NIH)

Not yet recruiting

Tailored COVID-19 Testing Support Plan for Francophone African Born Immigrants

COVID19 Testing
University of Rochester
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

Covid19

United States
BioTeke USA, LLC
CSSi Life Sciences

Completed

Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test

COVID-19

United States
Assiut University

Not yet recruiting

Cardiovascular Complications in Children With COVID 19

COVID 19 Associated Coagulopathy
University of Pennsylvania

Terminated

CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL

Leukemia, Acute Lymphoblastic

United States

Search clinical trials for: 19-195

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations